|
|
||||||||
4
1, and
4
7 Integrins Participate in CD4+ T Cell Recruitment to Chronically Inflamed Small Intestine1



,
,¶
* Digestive Health Center of Excellence,
Molecular Physiology and Biological Physics,
Cardiovascular Research Center,
Flow Cytometry Core Facility, and
¶ Departments of Biomedical Engineering, University of Virginia Health Sciences Center, Charlottesville, VA 22908
CD4+ T cells are essential for development and perpetuation of Crohns disease, a chronic immune-mediated condition that affects primarily the small intestine. Using novel models of Crohns disease-like ileitis (i.e., SAMP1/YitFc and CD4+ T cell transfer models), we have begun to understand the adhesive pathways that mediate lymphocyte trafficking to the chronically inflamed small bowel. Expansion of the CD4/
7+ population and increased mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression were observed within the intestinal lamina propria with disease progression. However, Ab blockade of the
7 integrin, the
4
7 heterodimer, MAdCAM-1, or L-selectin did not attenuate inflammation. Blockade of two pathways (L-selectin and MAdCAM-1 or
4 integrins) was required to improve ileitis. Further analyses showed that 55 ± 7% of the mesenteric lymph node
4
7+CD4 expressed L-selectin. These L-selectin+ T cells were the main producers of TNF-
and the predominant ileitis-inducing subpopulation. Mechanistically, combined blockade of L-selectin and MAdCAM-1 depleted the intestinal lamina propria of CD4+ T cells that aberrantly coexpressed
4
7 and
4
1 integrins, markedly decreasing local production of TNF-
and IFN-
. Thus, pathogenic CD4+ T cells not only use the physiologic
4
7/MAdCAM-1 pathway, but alternatively engage
4
1 and L-selectin to recirculate to the chronically inflamed small intestine.
This article has been cited by other articles:
![]() |
E. Smith, M. A. Stark, A. Zarbock, T. L. Burcin, A. C. Bruce, D. Vaswani, P. Foley, and K. Ley IL-17A Inhibits the Expansion of IL-17A-Producing T Cells in Mice through "Short-Loop" Inhibition via IL-17 Receptor J. Immunol., July 15, 2008; 181(2): 1357 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Miles, E. Liaskou, B. Eksteen, P. F. Lalor, and D. H. Adams CCL25 and CCL28 promote {alpha}4{beta}7-integrin-dependent adhesion of lymphocytes to MAdCAM-1 under shear flow Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1257 - G1267. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Smith, A. Zarbock, M. A. Stark, T. L. Burcin, A. C. Bruce, P. Foley, and K. Ley IL-23 Is Required for Neutrophil Homeostasis in Normal and Neutrophilic Mice J. Immunol., December 15, 2007; 179(12): 8274 - 8279. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saruta, Q. T. Yu, A. Avanesyan, P. R. Fleshner, S. R. Targan, and K. A. Papadakis Phenotype and Effector Function of CC Chemokine Receptor 9-Expressing Lymphocytes in Small Intestinal Crohn's Disease J. Immunol., March 1, 2007; 178(5): 3293 - 3300. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rivera-Nieves, T. L. Burcin, T. S. Olson, M. A. Morris, M. McDuffie, F. Cominelli, and K. Ley Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis J. Exp. Med., April 17, 2006; 203(4): 907 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ghosh, A. A. Chackerian, C. M. Parker, C. M. Ballantyne, and S. M. Behar The LFA-1 adhesion molecule is required for protective immunity during pulmonary Mycobacterium tuberculosis infection. J. Immunol., April 15, 2006; 176(8): 4914 - 4922. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fairweather, S. Frisancho-Kiss, D. B. Njoku, J. F. Nyland, Z. Kaya, S. A. Yusung, S. E. Davis, J. A. Frisancho, M. A. Barrett, and N. R. Rose Complement Receptor 1 and 2 Deficiency Increases Coxsackievirus B3-Induced Myocarditis, Dilated Cardiomyopathy, and Heart Failure by Increasing Macrophages, IL-1beta, and Immune Complex Deposition in the Heart J. Immunol., March 15, 2006; 176(6): 3516 - 3524. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bamias, M. R. Nyce, S. A. De La Rue, and F. Cominelli New Concepts in the Pathophysiology of Inflammatory Bowel Disease Ann Intern Med, December 20, 2005; 143(12): 895 - 904. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |